"Manipal Hospitals has worked closely with Dr Reddy s to create the state-of-the-art infrastructure to maintain Sputnik V vaccine," Manipal Health Enterprises Chief Operating Officer Karthik Rajagopal said.
The remarks by the Russian president came a day after the officials in New Delhi said that Serum Institute of India has received a preliminary approval from the country s drug regulator for manufacturing of Sputnik V.
At the close of trade, the market capitalisation of BSE-listed companies was at Rs 2,26,51,439.68 crore. Investors wealth gained Rs 1,88,767.14 crore helped by the market rally
India News: NEW DELHI: The DCGI has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik Covid-19 vaccine in India for examination,.